Index S&P 500 P/E 17.25 EPS (ttm) 28.52 Insider Own 0.44% Shs Outstand 233.07M Perf Week -5.38%
Market Cap 114.09B Forward P/E 11.81 EPS next Y 41.65 Insider Trans -5.15% Shs Float 230.92M Perf Month -9.21%
Income 6.69B PEG 1.43 EPS next Q 9.69 Inst Own 91.63% Short Float 0.95% Perf Quarter -7.03%
Sales 171.72B P/S 0.66 EPS this Y 12.41% Inst Trans 1.19% Short Ratio 2.18 Perf Half Y -3.53%
Book/sh 181.93 P/B 2.70 EPS next Y 11.81% ROA 6.02% Short Interest 2.20M Perf Year 10.85%
Cash/sh - P/C - EPS next 5Y 12.09% ROE 16.65% 52W Range 435.31 - 567.26 Perf YTD 4.34%
Dividend Est. 6.32 (1.28%) P/FCF 139.14 EPS past 5Y 12.18% ROI 10.02% 52W High -13.26% Beta 0.83
Dividend TTM 6.37 (1.29%) Quick Ratio - Sales past 5Y 13.24% Gross Margin - 52W Low 13.03% ATR (14) 10.00
Dividend Ex-Date Sep 10, 2024 Current Ratio 1.49 EPS Y/Y TTM 6.53% Oper. Margin 5.48% RSI (14) 21.46 Volatility 2.24% 1.77%
Employees 104900 Debt/Eq 0.66 Sales Y/Y TTM 3.62% Profit Margin 3.90% Recom 1.61 Target Price 607.61
Option/Short Yes / Yes LT Debt/Eq 0.58 EPS Q/Q 26.46% Payout 23.47% Rel Volume 1.54 Prev Close 492.07
Sales Surprise 0.55% EPS Surprise 1.22% Sales Q/Q -0.06% Earnings Jul 17 BMO Avg Volume 1.01M Price 492.02
SMA20 -7.12% SMA50 -8.08% SMA200 -4.98% Trades
Volume 1,551,395 Change -0.01%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-18-24 Downgrade BofA Securities
Buy → Neutral
$646 → $530
Jun-24-24 Initiated Morgan Stanley
Overweight
$643
May-30-24 Initiated Robert W. Baird
Outperform
$649
Mar-06-24 Initiated Barclays
Overweight
$584
Jul-12-23 Downgrade Wolfe Research
Outperform → Peer Perform
Apr-27-23 Upgrade Morgan Stanley
Equal-Weight → Overweight
$500 → $571
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$547
Mar-28-23 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$523 → $572
Sep-09-22 Upgrade BofA Securities
Neutral → Buy
$535 → $575
Aug-22-22 Upgrade SVB Leerink
Mkt Perform → Outperform
$490 → $580
Today 03:22PM
10:59AM
08:00AM
06:17AM
Oct-04-24 01:22PM
01:00PM
Loading…
Oct-02-24 01:00PM
Sep-30-24 10:45AM
Sep-26-24 10:20AM
Sep-25-24 01:49PM
Sep-13-24 05:08AM
Sep-05-24 12:58PM
07:59AM
Aug-29-24 03:01AM
Aug-25-24 04:22PM
Aug-22-24 03:09PM
04:40PM
Loading…
Aug-20-24 04:40PM
Aug-19-24 08:39AM
Aug-16-24 11:30AM
Aug-13-24 07:08PM
Aug-12-24 10:00AM
Aug-06-24 11:30PM
Aug-02-24 07:43AM
Jul-31-24 05:00PM
Jul-29-24 03:29PM
Jul-26-24 10:40PM
Jul-25-24 07:00AM
(The Wall Street Journal)
Jul-23-24 12:23AM
Jul-19-24 12:33PM
(The Wall Street Journal)
Jul-18-24 02:58AM
(Thomson Reuters StreetEvents)
01:01AM
01:33PM
Loading…
Jul-17-24 01:33PM
12:00PM
10:52AM
10:42AM
10:16AM
(The Wall Street Journal)
10:02AM
(The Wall Street Journal)
09:30AM
07:10AM
06:18AM
06:17AM
(The Wall Street Journal)
06:06AM
(Associated Press Finance)
06:00AM
Jul-16-24 09:40AM
Jul-12-24 02:40PM
09:15AM
Jul-10-24 10:00AM
Jul-08-24 01:00PM
12:22PM
Jul-04-24 05:30AM
(The Wall Street Journal)
Jul-03-24 07:50AM
Jun-30-24 11:42AM
Jun-28-24 09:40AM
Jun-27-24 03:56PM
(Investor's Business Daily)
Jun-26-24 04:05PM
Jun-23-24 10:25AM
Jun-20-24 12:22PM
Jun-19-24 03:25PM
12:02PM
Jun-14-24 11:00AM
Jun-13-24 09:16PM
(The Wall Street Journal)
12:56PM
09:45AM
Jun-12-24 12:31PM
09:40AM
Jun-10-24 07:01AM
Jun-07-24 10:16PM
Jun-03-24 11:22AM
May-30-24 04:05PM
May-28-24 09:45AM
May-27-24 09:40AM
May-24-24 05:09PM
May-22-24 05:17PM
May-21-24 12:39PM
May-20-24 04:05PM
May-10-24 09:45AM
May-09-24 09:40AM
09:15AM
May-01-24 09:30AM
Apr-29-24 05:22PM
Apr-26-24 09:50AM
02:25AM
Apr-25-24 05:16PM
12:00PM
Apr-24-24 09:45AM
Apr-23-24 09:40AM
Apr-22-24 07:00AM
(The Wall Street Journal)
Apr-19-24 09:32AM
03:02AM
01:01AM
Apr-18-24 11:49PM
(Thomson Reuters StreetEvents)
04:27PM
03:53PM
12:15PM
11:58AM
11:18AM
10:53AM
10:45AM
(The Wall Street Journal)
09:41AM
09:30AM
08:15AM
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PERU RAMIRO G Director Aug 05 '24 Sale 531.52 753 400,235 8,744 Aug 06 05:23 PM RAMIRO G PERU Director Aug 05 '24 Proposed Sale 531.52 753 400,235 Aug 05 04:14 PM BOUDREAUX GAIL President and CEO Jul 22 '24 Sale 500.98 34,000 17,033,395 126,709 Jul 23 05:02 PM Dixon Robert L JR Director Jul 19 '24 Sale 506.76 305 154,562 9,721 Jul 22 04:30 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 23 '24 Option Exercise 238.27 5,473 1,304,052 45,571 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 24 '24 Option Exercise 238.27 2,043 486,786 33,503 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 23 '24 Sale 533.74 14,111 7,531,565 31,460 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 24 '24 Sale 532.44 6,199 3,300,590 27,304 Apr 25 05:05 PM Kendrick Charles Morgan JR EVP & President, Commercial Mar 08 '24 Sale 500.46 2,432 1,217,119 15,840 Mar 12 04:26 PM Penczek Ronald W CAO & Controller Mar 06 '24 Sale 504.58 916 462,195 1,764 Mar 08 04:16 PM Haytaian Peter D EVP & Pres Carelon & CarelonRx Mar 04 '24 Option Exercise 166.97 15,000 2,504,550 39,982 Mar 05 04:24 PM Haytaian Peter D EVP & Pres Carelon & CarelonRx Mar 04 '24 Sale 500.18 21,095 10,551,297 18,887 Mar 05 04:24 PM PERU RAMIRO G Director Feb 07 '24 Sale 500.00 753 376,500 9,109 Feb 09 04:22 PM Todt Blair Williams EVP, CLO & CAO Dec 14 '23 Option Exercise 311.48 5,492 1,710,648 18,004 Dec 15 04:28 PM Todt Blair Williams EVP, CLO & CAO Dec 14 '23 Sale 484.02 5,492 2,658,238 12,512 Dec 15 04:28 PM Penczek Ronald W CAO & Controller Nov 30 '23 Sale 475.17 1,055 501,304 1,787 Dec 01 04:21 PM Penczek Ronald W CAO & Controller Oct 24 '23 Sale 454.35 64 29,078 2,842 Oct 26 04:15 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
